Man Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Man Group’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-169,281	Closed	-$10.1M	–	2025
2019 Q4	$10.1M	Buy	169,281 +93,727	+124%	+$3.52M	0.03%	687
2019 Q3	$2.12M	Sell	75,554 -11,166	-13%	-$381K	0.01%	1224
2019 Q2	$3.28M	Buy	+86,720	New	+$3.33M	0.01%	1131
2018 Q2	–	Sell	-32,018	Closed	-$962K	–	2292
2018 Q1	$962K	Buy	+32,018	New	+$1.08M	﹤0.01%	1538

Man Group's BOLD Position: Q1 2020 in Review

Man Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 169,281 shares — an estimated $10.1M sold.

Man Group first reported a position in BOLD in Q1 2018 and held it in 4 quarters. The position peaked at $10.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Man Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Man Group sold 169,281 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $10.1M.
Man Group first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 4 quarters.
Man Group's Audentes Therapeutics, Inc position peaked at $10.1M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Man Group's 13F filing for Q1 2020, filed 15 May 2020.